• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年肝细胞癌患者肝切除术后的手术结果和肝再生。

Surgical Outcome and Hepatic Regeneration after Hepatic Resection for Hepatocellular Carcinoma in Elderly Patients.

机构信息

Department of General and Gastroenterological Surgery, Osaka Medical College Hospital, Osaka, Japan,

Department of General and Gastroenterological Surgery, Osaka Medical College Hospital, Osaka, Japan.

出版信息

Dig Surg. 2019;36(4):289-301. doi: 10.1159/000488327. Epub 2018 May 14.

DOI:10.1159/000488327
PMID:29758561
Abstract

INTRODUCTION

The rising proportion of elderly patients (aged 80 yearsor above) in our population means that more elderly patients are undergoing hepatectomy.

METHODS

Five-hundred and thirty patients who underwent hepatectomy for hepatocellular carcinoma (HCC) were retrospectively analyzed with respect to their preoperative status and perioperative results, including remnant liver regeneration. The remnant liver volume was postoperatively measured with multidetector CT on postoperative day 7 and 1, 2, 5, and 12 months after surgery. An elderly group (aged 80 or older) was compared with a non-elderly group (aged less than 80 years).

RESULTS

Underlying diseases of the cardiovascular system were significantly more common in the elderly group (57.8%, p = 0.0008). The postoperative incidence of Clavien-Dindo Grade IIIa or higher complications was 20.0% in the elderly group and 24.3% in the non-elderly group, and this difference was not significant. As for regeneration of the remnant liver after resection, this was not morphologically delayed compared to the non-elderly group.

CONCLUSIONS

In this study, we have demonstrated that safe, radical hepatectomy, similar to procedures performed on non-elderly patients, can be performed on patients with HCC aged 80 and older with sufficient perioperative care.

摘要

简介

随着人口老龄化的加剧,80 岁及以上的老年患者在我们的人群中所占比例越来越高,这意味着越来越多的老年患者需要接受肝切除术。

方法

回顾性分析了 530 例因肝细胞癌(HCC)接受肝切除术的患者的术前状况和围手术期结果,包括残肝再生情况。术后第 7 天、1 天、2 天、5 天和 12 个月,采用多排螺旋 CT 测量术后残肝体积。将老年组(年龄 80 岁及以上)与非老年组(年龄<80 岁)进行比较。

结果

老年组患者心血管系统基础疾病明显更为常见(57.8%,p=0.0008)。老年组术后 Clavien-Dindo 分级 IIIa 或更高并发症的发生率为 20.0%,非老年组为 24.3%,差异无统计学意义。就切除后残肝的再生而言,与非老年组相比,其形态上没有延迟。

结论

在这项研究中,我们证明了在充分的围手术期护理下,安全、根治性的肝切除术可以安全地应用于年龄在 80 岁及以上的 HCC 患者,与非老年患者的手术方式相似。

相似文献

1
Surgical Outcome and Hepatic Regeneration after Hepatic Resection for Hepatocellular Carcinoma in Elderly Patients.老年肝细胞癌患者肝切除术后的手术结果和肝再生。
Dig Surg. 2019;36(4):289-301. doi: 10.1159/000488327. Epub 2018 May 14.
2
Liver Regeneration After Major Liver Resection for Hepatocellular Carcinoma in the Elderly.老年肝细胞癌患者肝大部切除术后的肝再生
J Invest Surg. 2020 Apr;33(4):332-338. doi: 10.1080/08941939.2018.1517839. Epub 2018 Nov 2.
3
Volumetric and Functional Regeneration of Remnant Liver after Hepatectomy.肝切除术后残肝的体积和功能再生。
J Gastrointest Surg. 2019 May;23(5):914-921. doi: 10.1007/s11605-018-3985-5. Epub 2018 Sep 27.
4
Techniques of parenchyma-sparing hepatectomy for the treatment of tumors involving the hepatocaval confluence: A reliable way to assure an adequate future liver remnant volume.保留肝实质肝切除术治疗累及肝腔静脉汇合部肿瘤的技术:确保足够未来肝剩余体积的可靠方法。
Surgery. 2017 Sep;162(3):483-499. doi: 10.1016/j.surg.2017.02.019. Epub 2017 May 24.
5
Value of MR elastography for the preoperative estimation of liver regeneration capacity in patients with hepatocellular carcinoma.磁共振弹性成像在肝细胞癌患者肝再生能力术前评估中的价值。
J Magn Reson Imaging. 2017 Jun;45(6):1627-1636. doi: 10.1002/jmri.25517. Epub 2016 Nov 16.
6
Right hepatic lobectomy in elderly patients with hepatocellular carcinoma.老年肝细胞癌患者的右肝叶切除术
Hepatogastroenterology. 1997 Mar-Apr;44(14):514-8.
7
The Effects of Allogeneic Blood Transfusion in Hepatic Resection.同种异体输血对肝切除术的影响。
Am Surg. 2021 Feb;87(2):228-234. doi: 10.1177/0003134820950285. Epub 2020 Sep 15.
8
The efficacy and safety of totally laparoscopic hepatectomy for non-cirrhotic hepatocellular carcinoma in the elderly.老年非肝硬化肝细胞癌全腹腔镜肝切除术的疗效与安全性
BMC Surg. 2018 Dec 17;18(1):118. doi: 10.1186/s12893-018-0444-x.
9
Hepatic resection for hepatocellular carcinoma in elderly patients.老年患者肝细胞癌的肝切除术
Hepatogastroenterology. 2004 Jan-Feb;51(55):219-23.
10
Human early liver regeneration after hepatectomy in patients with hepatocellular carcinoma: special reference to age.肝癌患者肝切除术后的早期肝再生:特别关注年龄因素。
Scand J Surg. 2013;102(2):101-5. doi: 10.1177/1457496913482250.

引用本文的文献

1
A biomarker framework for liver aging: the Aging Biomarker Consortium consensus statement.肝脏衰老的生物标志物框架:衰老生物标志物联盟共识声明。
Life Med. 2024 Jan 30;3(1):lnae004. doi: 10.1093/lifemedi/lnae004. eCollection 2024 Feb.
2
Development and validation of nomogram to predict overall survival and disease-free survival after surgical resection in elderly patients with hepatocellular carcinoma.预测老年肝细胞癌患者手术切除后总生存期和无病生存期的列线图的开发与验证
Front Oncol. 2024 May 24;14:1395740. doi: 10.3389/fonc.2024.1395740. eCollection 2024.
3
A Novel Nomogram to Predict Prognosis in Elderly Early-Stage Hepatocellular Carcinoma Patients After Ablation Therapy.
一种预测老年早期肝细胞癌患者消融治疗后预后的新型列线图。
J Hepatocell Carcinoma. 2024 May 17;11:901-911. doi: 10.2147/JHC.S459250. eCollection 2024.
4
Efficacy and Safety of Surgical Resection in Elderly Patients with Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.老年肝细胞癌患者手术切除的疗效和安全性:系统评价和荟萃分析。
Gut Liver. 2024 Jul 15;18(4):695-708. doi: 10.5009/gnl230485. Epub 2024 May 7.
5
A Comparison of Short-Term Outcomes between Laparoscopic and Open Liver Resection in Elderly Patients.老年患者腹腔镜与开腹肝切除术短期结局的比较
J Minim Invasive Surg. 2020 Dec 15;23(4):179-185. doi: 10.7602/jmis.2020.23.4.179.
6
Hepatocellular carcinoma in old age: are there any benefits of liver resection in old age?老年肝细胞癌:老年患者行肝切除术有任何益处吗?
Ann Surg Treat Res. 2020 Aug;99(2):65-71. doi: 10.4174/astr.2020.99.2.65. Epub 2020 Jul 31.
7
Cirrhotic patients and older people.肝硬化患者和老年人。
World J Hepatol. 2019 Sep 27;11(9):663-677. doi: 10.4254/wjh.v11.i9.663.
8
Effective therapeutic options for elderly patients with hepatocellular carcinoma: A nationwide cohort study.老年肝细胞癌患者的有效治疗选择:一项全国性队列研究。
Medicine (Baltimore). 2019 Jul;98(30):e16150. doi: 10.1097/MD.0000000000016150.
9
GSK923295 as a potential antihepatocellular carcinoma agent causing delay on liver regeneration after partial hepatectomy.GSK923295 作为一种潜在的抗肝癌药物,可导致部分肝切除术后肝脏再生延迟。
Chin Med J (Engl). 2019 Feb 5;132(3):311-318. doi: 10.1097/CM9.0000000000000053.
10
NQO1-Selective Activated Prodrug of Triptolide: Synthesis and Antihepatocellular Carcinoma Activity Evaluation.雷公藤甲素的NQO1选择性激活前药:合成及抗肝细胞癌活性评价
ACS Med Chem Lett. 2018 Nov 27;9(12):1253-1257. doi: 10.1021/acsmedchemlett.8b00404. eCollection 2018 Dec 13.